Ophthalmology Therapeutics: Does current pipeline innovation hold the potential to affect the future ophthalmology market?

This Frontier Pharma: Ophthalmology Therapeutics assesses first-in-class innovation in the ophthalmology pipeline, highlighting key trends in the distribution of these products.

Pune, India - March 14, 2018 /MarketersMedia/ —

The pipeline is varied in terms of molecular targets and molecule types. Products acting on the immune system and neurotransmitter signaling are the most prevalent, but no single target dominates by any clear margin. There are a total of 194 first-in class pipeline products in development for ophthalmologic indications 38% of the 512 pipeline products for which there is a disclosed molecular target. Encompassing gene therapies, slowing of the visual cycle and antisense therapies, the pipeline appears robust and has huge potential to strengthen treatment options for ophthalmological disorders.

Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-ophthalmology-therapeutics-gene-therapies-and-first-in-class-targets-offer-novel-treatments-for-substantial-unmet-needs-in-a-pipeline-dominated-by-angiogenic-and-immune-signaling-drugs

Reasons To Buy
• Understand the current clinical and commercial landscape. This includes a comprehensive study of disease pathogenesis, diagnosis and prognosis, and the treatment options available.
• Visualize the composition of the ophthalmological disorders market in terms of dominant molecule types and targets, and understand the current unmet needs and how they can be addressed. This knowledge allows a competitive understanding of gaps in the market.
• Analyze the ophthalmological disorders pipeline and stratify by stage of development, molecule type and molecular target. There are strong signs in the pipeline that the industry is seeking novel approaches to treating ophthalmological disorders to overcome the overwhelming level of unmet need.
• Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising early-stage targets have been reviewed in greater detail.
• Identify commercial opportunities in the ophthalmological disorders deals landscape by analyzing trends in licensing and co-development deals, and a curated list of ophthalmological disorder therapies that have not yet been involved in deals, and may offer potential investment opportunities.

Get this report at: https://www.themarketreports.com/report/buy-now/935550

In the past the ophthalmological disorders therapy area has suffered from a lack of full understanding of the pathophysiology and underlying mechanisms of the diseases. However, as this knowledge has improved vastly in recent years, potential targets have been identified for treatment. As well as the main disorders previously mentioned, there is also interest in developing treatments for indications such as allergic conjunctivitis and retinitis pigmentosa. The approval of a gene therapy for retinitis pigmentosa is indicative of this progress, and represents the first gene therapy approved for an inherited condition by the FDA.

Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/935550

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/ophthalmology-therapeutics-does-current-pipeline-innovation-hold-the-potential-to-affect-the-future-ophthalmology-market/314326

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-ophthalmology-therapeutics-gene-therapies-and-first-in-class-targets-offer-novel-treatments-for-substantial-unmet-needs-in-a-pipeline-dominated-by-angiogenic-and-immune-signaling-drugs%20%20

Source: MarketersMedia

Release ID: 314326

More News From sports.morningdispatcher.com

Quetta wins 1st PSL title, beats Peshawar in final

Mar 19, 2019

KARACHI, Pakistan — Quetta Gladiators won its first Pakistan Super League Twenty20 title on Sunday with a thumping eight-wicket victory over 2017 champions Peshawar Zalmi in the final. Darren Sammy-led Peshawar, playing in its third straight PSL final, was restricted to 138-8 after being put into bat by Quetta captain Sarfaraz Ahmed. Improving paceman Mohammad Hasnain claimed 3-30 from his four overs. In reply, Ahmed Shehzad (58 not out off 51 balls) led Quetta to 139-2 in 17.5 overs after former Australia international Shane Watson was run out early for seven in the run-chase. South African Rilee Rossouw remained unbeaten...

Puyol among thousands to watch PSL final

Mar 19, 2019

KARACHI, Pakistan — Legendary Spanish footballer Carles Puyol was among thousands of cricket fans at the National Stadium to witness the Pakistan Super League twenty20 final on Sunday. Puyol, a former Barcelona defender, is in the southern port city of Karachi to promote next month's exhibition matches in Pakistan. Brazilian Kaka will be among a host of other international footballers who will be taking part in Lahore and Karachi. "It's an amazing welcome, the people are very friendly. I'm very happy to be here," Puyol told a capacity crowd of 32,000 present when he was invited onto the stage during...

Peshawar through to 3rd successive PSL final

Mar 19, 2019

KARACHI, Pakistan — Kamran Akmal's blistering half century propelled 2017 winner Peshawar Zalmi to its third straight Pakistan Super League final with a convincing 48-run victory over defending champion Islamabad United on Friday. Peshawar will take on Quetta Gladiators on Sunday in a repeat of the final two years ago. A minute's silence was observed before the start of eliminator 2 in memory of those who died in deadly attacks on two mosques in New Zealand earlier on Friday. Players and officials also wore black armbands during the match at a packed 32,000-capacity National Stadium. Pakistan Cricket Board chairman Ehsan...

Australian Watson carries Quetta to PSL final

Mar 19, 2019

KARACHI, Pakistan — Shane Watson's all-round performance carried Quetta Gladiators to its third Pakistan Super League final with a 10-run victory over Peshawar Zalmi in the qualifier on Wednesday. Peshawar will have another chance to make it to the final when it takes on the winner between Karachi Kings and defending champions Islamabad United. Watson smashed 71 off 43 balls with six sixes and five boundaries and lifted Quetta to 186-6 after Peshawar captain Darren Sammy of the West Indies won the toss and elected to field. Sammy (46) and Kieron Pollard (44) led a gallant Peshawar fightback with an...

Australia beats India by 35 runs in deciding 5th ODI

Mar 19, 2019

NEW DELHI — Australia beat India by 35 runs to win the fifth and final ODI on Wednesday and secure a 3-2 victory in the series. It is the first ODI series' win for Australia since January 2017 and the fourth on Indian soil, the last coming in 2009. It was India's first loss in an ODI series at home since 2015 when they lost 3-2 to South Africa. Usman Khawaja (100) struck his second century in three ODIs as Australia rode to 272-9. Peter Handscomb also followed his hundred in Mohali with 52 off 60 balls, as the duo...

About Us

Get all the up-to-date breaking news about politics, business, entertainment, sports, lifestyles, weather, traffic, and local news in a seamless digital environment only in Morning Dispatcher.

Contact us: sales[at]morningdispatcher.com

Subscribe Now!

Quick Links

HomePress